SynthesisInternational journal of clinical pharmacy2015

Risk of treatment-related mortality with sorafenib in cancer patients: a meta-analysis of 20 randomly controlled trials : Risk of sorafenib-associated death.

Xiongwen Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.